Antibiotic resistance of urinary tract pathogens and rationale for empirical intravenous therapy

Pediatric Nephrology : Journal of the International Pediatric Nephrology Association
Maria HallerReinhard Berner

Abstract

Empirical antibiotic treatment in urinary tract infection (UTI) in children must rely on surveillance data on the epidemiology and resistance patterns of common uropathogens. A retrospective analysis of bacteria isolated from children with UTI irrespective of underlying disease or pre-treatment was performed at the University Hospital of Freiburg, Germany, in 1997, and from 1999 to 2001. In the first study period, 261 positive urine samples and in the second period 684 positive samples were analyzed. Escherichia coli (57.2%) was the leading uropathogen followed by Enterococcus spp. (13.7%), Pseudomonas aeruginosa (7.0%), Proteus spp. (5.9%), Klebsiella spp. (4.7%), and Enterobacter/Citrobacter spp. (4.3%). Almost 50% of the E. coli isolates were resistant to ampicillin, but effectively no resistance against cephalosporins, aminogylcosides, ciprofloxacin, nitrofurantoin, and imipenem was observed. In Enterococcus spp. the resistance to ampicillin was about 15% and 40% to netilmicin, while none of the latter showed high-level aminoglycoside resistance. In P. aeruginosa, there was no resistance to aminoglycosides. No difference in resistance patterns between the two study periods was observed. We conclude that an empirical combina...Continue Reading

Citations

Jun 30, 2006·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Ibrahim GökçeNihal Ozdemir
Jan 17, 2008·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Ulrike John, Markus J Kemper
Jan 15, 2008·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Martina PrelogLothar Bernd Zimmerhackl
Jul 29, 2009·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Maria BitsoriEmmanouil Galanakis
Mar 18, 2005·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·M FritzscheC Aebi
Jun 5, 2010·International Urology and Nephrology·Elpis MantadakisAthanassios Chatzimichael
Dec 24, 2013·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Maria BitsoriEmmanouil Galanakis
Nov 26, 2011·The Journal of Urology·M BitsoriE Galanakis
Nov 1, 2011·International Journal of Antimicrobial Agents·Rolf Beetz, Martin Westenfelder
Sep 27, 2006·International Journal of Antimicrobial Agents·Selçuk YükselFatoş Yalçinkaya
Nov 30, 2006·Journal of Chemotherapy·A A ElmanamaF H Abu-Elamreen
Mar 9, 2012·International Braz J Urol : Official Journal of the Brazilian Society of Urology·Hamid Mohammad-JafariAli-Reza Khalilian
Feb 3, 2018·Pediatrics International : Official Journal of the Japan Pediatric Society·Jun WangYunfei Guo
Dec 11, 2008·Pediatrics International : Official Journal of the Japan Pediatric Society·Min-Hua TsengChih-Chien Wang
Jul 27, 2007·Scandinavian Journal of Infectious Diseases·Maria AnatoliotakiAmalia Tsilimigaki
Jun 20, 2014·Journal of Pediatric Hematology/oncology·Hiroaki KanaiYoshichika Takei
May 13, 2017·BioMed Research International·Antonio Sorlózano-PuertoJosé Gutiérrez-Fernández
Mar 24, 2018·Global Health Research and Policy·Suzan Gunduz, Hatice Uludağ Altun
Dec 18, 2020·Epidemiology and Infection·P VachvanichsanongP Dissaneewate

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.